{"id":"https://openalex.org/W2080227147","doi":"https://doi.org/10.1177/1352458508091369","title":"Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France","display_name":"Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-23","ids":{"openalex":"https://openalex.org/W2080227147","doi":"https://doi.org/10.1177/1352458508091369","mag":"2080227147","pmid":"https://pubmed.ncbi.nlm.nih.gov/18573824"},"language":"en","primary_location":{"id":"doi:10.1177/1352458508091369","doi":"https://doi.org/10.1177/1352458508091369","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1352458508091369","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2080227147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079607840","display_name":"Christine Lebrun\u2010Fr\u00e9nay","orcid":"https://orcid.org/0000-0002-3713-2416","observed_orcids":["https://orcid.org/0000-0002-3713-2416"]},"institutions":[{"id":"https://openalex.org/I4210143244","display_name":"H\u00f4pital Pasteur","ror":"https://ror.org/056b4pm25","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210143244"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"C Lebrun","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Pasteur, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Pasteur, Nice, France","institution_ids":["https://openalex.org/I4210143244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105838820","display_name":"Marc Debouverie","orcid":"https://orcid.org/0000-0002-6659-6148","observed_orcids":["https://orcid.org/0000-0002-6659-6148"]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Debouverie","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Central, Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Central, Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112796456","display_name":"Severine Jeannin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143244","display_name":"H\u00f4pital Pasteur","ror":"https://ror.org/056b4pm25","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210143244"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S Jeannin","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Pasteur, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Pasteur, Nice, France","institution_ids":["https://openalex.org/I4210143244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082409953","display_name":"S. Pittion\u2010Vouyovitch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S Pittion-Vouyovitch","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Central, Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Central, Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029422667","display_name":"Caroline Bayreuther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143244","display_name":"H\u00f4pital Pasteur","ror":"https://ror.org/056b4pm25","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210143244"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Bayreuther","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Pasteur, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Pasteur, Nice, France","institution_ids":["https://openalex.org/I4210143244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088472549","display_name":"Fr\u00e9d\u00e9ric Berthier","orcid":"https://orcid.org/0000-0002-5802-8503","observed_orcids":["https://orcid.org/0000-0002-5802-8503"]},"institutions":[{"id":"https://openalex.org/I4210143244","display_name":"H\u00f4pital Pasteur","ror":"https://ror.org/056b4pm25","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210143244"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F Berthier","raw_affiliation_strings":["MS clinic, Neurology, University Hospital Pasteur, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MS clinic, Neurology, University Hospital Pasteur, Nice, France","institution_ids":["https://openalex.org/I4210143244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079607840"],"corresponding_institution_ids":["https://openalex.org/I4210143244"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.2031,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.56088469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"14","issue":"7","first_page":"933","last_page":"939"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/maghrebi-immigrants","display_name":"Maghrebi immigrants","score":0.968999981880188},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8880000114440918},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.7699999809265137},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.9490000009536743},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":1.0},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.7210000157356262},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.7020000219345093},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7490000128746033},{"id":"https://openalex.org/keywords/treatment-timing","display_name":"treatment timing","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.9098918437957764},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.568306565284729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4950031638145447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15799841284751892},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.143572598695755}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000352","descriptor_name":"Africa, Northern","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014171","descriptor_name":"Transients and Migrants","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1352458508091369","doi":"https://doi.org/10.1177/1352458508091369","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1352458508091369","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmid:18573824","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18573824","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1982355523","https://openalex.org/W2016184377","https://openalex.org/W2020134202","https://openalex.org/W2050737501","https://openalex.org/W2062684133","https://openalex.org/W2072118735","https://openalex.org/W2081169442","https://openalex.org/W2084654443","https://openalex.org/W2133472515","https://openalex.org/W2146286942","https://openalex.org/W2148186809","https://openalex.org/W2149587664","https://openalex.org/W2162856900","https://openalex.org/W2170115175","https://openalex.org/W2326826867","https://openalex.org/W2916040650"],"related_works":["https://openalex.org/W2081169442","https://openalex.org/W3037924620","https://openalex.org/W2591013653","https://openalex.org/W4392848466","https://openalex.org/W7164055768","https://openalex.org/W880797180","https://openalex.org/W4415624337","https://openalex.org/W7038943755","https://openalex.org/W4283390555","https://openalex.org/W2793286365"],"abstract_inverted_index":{"BACKGROUND:":[0],"Multiple":[1],"Sclerosis":[2],"in":[3,23,55,83,94,118,139],"North":[4],"African":[5],"migrants":[6],"(MS-NA)":[7],"is":[8],"more":[9,29,257],"aggressive":[10],"with":[11,31,86,111,187,209],"mostly":[12],"primary":[13],"progressive":[14,226],"forms":[15],"and":[16,60,70,75,114,224,255],"cerebellar":[17],"symptoms.":[18],"Despite":[19],"an":[20,66,169],"earlier":[21,200,252],"onset":[22],"NA":[24,84,196],"patients,":[25,131],"the":[26,39,46,56,77,89,123,135,140,147,158,173,210,251,256],"disease":[27],"progresses":[28],"rapidly,":[30],"a":[32,42,50,61,101],"higher":[33,51],"proportion":[34],"showing":[35],"incomplete":[36],"recovery":[37],"from":[38,155],"first":[40,47,57,148],"relapse,":[41],"shorter":[43,62],"time":[44,63,154],"between":[45],"two":[48],"relapses,":[49],"number":[52],"of":[53,68,79,105,129,134,160,165,175,182,213,260],"relapses":[54],"5":[58],"years,":[59,207],"to":[64,157,248],"reach":[65],"EDSS":[67,170,235],"4.0":[69],"6.0.":[71],"We":[72,99],"collected":[73],"data":[74],"studied":[76],"impact":[78],"disease-modifying":[80],"therapies":[81],"(DMT)":[82],"patients":[85,92,137,167,183,197,240,247],"MS,":[87],"among":[88],"4144":[90],"MS":[91,96,246],"treated":[93,185,199],"our":[95,119],"clinics.":[97],"METHODS:":[98],"performed":[100],"descriptive":[102],"population-based":[103],"study":[104],"MS-NA":[106,136,166,239],"patients.":[107],"Data":[108],"were":[109,142,184,198],"crossed":[110],"expected":[112],"age-":[113],"gender-matched":[115],"characteristics":[116],"available":[117],"EDMUS":[120],"databases":[121],"for":[122,216,225],"period":[124],"1995-2007.":[125],"RESULTS:":[126],"A":[127,180],"total":[128],"133":[130],"representing":[132],"66%":[133],"included":[138],"database":[141],"identified:":[143],"mean":[144,153],"age":[145],"at":[146,172],"documented":[149],"symptom:":[150],"29.7":[151],"years;":[152],"diagnosis":[156,202],"beginning":[159,174],"DMT:":[161],"1.2":[162],"years.":[163],"40%":[164],"had":[168],">3":[171],"treatment":[176,253],"(vs.":[177],"25%;":[178],"P=0.002).":[179],"majority":[181],"initially":[186],"immunomodulatory":[188],"drugs":[189],"(MS-NA:":[190],"48%":[191],"vs.":[192,205,221,230],"CT:":[193],"51%,":[194],"P=0.8).":[195],"after":[201],"(1.3":[203],"years":[204],"4.5":[206],"P=0.003),":[208],"frequent":[211,258],"use":[212,259],"immunosuppressive":[214],"drugs:":[215],"remitting":[217],"forms,":[218,227],"mitoxantrone":[219],"(18.5%":[220],"7.8%,":[222],"P=0.0001)":[223],"cyclophosphamide":[228],"(38%":[229],"28%,":[231],"P=0.003).":[232],"CONCLUSIONS:":[233],"Considering":[234],"follow-up":[236],"during":[237],"DMT,":[238],"appear":[241],"as":[242,244],"responsive":[243],"other":[245],"treatment,":[249],"despite":[250],"prescription":[254],"immunosuppressors.":[261]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2080227147","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
